← Back to Search

Microbiota Therapy

Fecal Microbiota Transplantation for Gastrointestinal Disorders After HCT

Phase 1
Waitlist Available
Led By Gabriela Maron, MD
Research Sponsored by St. Jude Children's Research Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
No Placebo-Only Group

Summary

This trial studies if FMT is safe and effective for treating GI symptoms after HCT.

Who is the study for?
This trial is for children under 22 who've had a bone marrow transplant at least 30 days ago and are now having serious gut problems that steroids can't fix or keep coming back when trying to stop steroid treatment. They shouldn't be pregnant, have had previous FMT, recent belly surgery, devices in their abdomen (except certain feeding tubes), or be on dialysis.
What is being tested?
The study tests if putting healthy stool from donors into the child's intestines is safe and could work for treating stubborn gut issues after a bone marrow transplant. It looks at how well kids handle this treatment and if it helps with their symptoms.
What are the potential side effects?
Possible side effects of fecal transplants include stomach pain, bloating, diarrhea or constipation, fever, infection risk due to bacteria in the stool sample used for transplantation. The exact side effects can vary based on individual reactions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Proportion of participants providing all protocol required stool samples
Proportion of participants that drop up post-enrollment
Proportion of participants with a non-serious adverse event occurring within 30 days following FMT
+3 more
Secondary study objectives
Percentage of participants who reduce or discontinue steroids at the end of the study
Proportion of participants with a complete response or a partial response

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Stratum BExperimental Treatment1 Intervention
GI Dysfunction
Group II: Stratum AExperimental Treatment1 Intervention
Diagnosed with GvHD
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fecal microbiota transplant (FMT)
2015
Completed Phase 2
~40

Find a Location

Who is running the clinical trial?

St. Jude Children's Research HospitalLead Sponsor
443 Previous Clinical Trials
5,305,461 Total Patients Enrolled
Gabriela Maron, MDPrincipal InvestigatorSt. Jude Children's Research Hospital
1 Previous Clinical Trials
2,000 Total Patients Enrolled

Media Library

Fecal microbiota transplant (FMT) (Microbiota Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05664113 — Phase 1
Gastrointestinal Disorder Research Study Groups: Stratum A, Stratum B
Gastrointestinal Disorder Clinical Trial 2023: Fecal microbiota transplant (FMT) Highlights & Side Effects. Trial Name: NCT05664113 — Phase 1
Fecal microbiota transplant (FMT) (Microbiota Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05664113 — Phase 1
~10 spots leftby Dec 2024